NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I believe, once published, there will be coverage and there will likely be more investing and movement of the stock. You never know if you’ll get that kind of powerful spike. We got an anticipatory spike for the NYAS presentation but then the market realized it was not what we were waiting for and that Adam Feuerstein beat the media.

But going forward I would expect that we will likely be much higher certainly than now, whether a lot higher than where we were before, I have no idea, but that frequently occurs upon good news with oncology drugs. So I think there is a good chance. I am not necessarily anticipating a run to what some are expecting, but if it happened I would be thrilled. It depends how the market comes to perceive the news. I’d be thrilled if we ran to $4 to $5. If it went higher I’d be even more thrilled.

If they are producing revenues sooner than anticipated and the UK is covering patients sooner than expected, those kinds of things can have a real impact. If they have deals, that can set a real baseline for more appreciation.

But right now we’re just waiting for things to develop. Who knows, they may be waiting for certain events to trigger other events before they schedule the ASM, to make it a more meaningful event. You never know when a company is so pregnant with possibilities as NWBO is right now.